Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | CVP, Business Transformation | December 30, 2016 | January 03, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date December 30, 2016 · Filed January 03, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Comp Plan Baxter Common Stock FundSEC Table II · derivative / convertible security | Direct | 5,502 |
Reported balance
After 2016-12-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-12-30 · Grant · Acquired 49 · Balance 5,502 F1: 1 for 1 F2: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: 1 for 1
F2: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2016 Filed Jan 3, 2017 21:23 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 49 | $44.34 | $2,172.66 |
DisclosureSEC source: 0001645279-17-000001 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,502 Underlying: Common Stock Fund, $1 par value · 49 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:11 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 49 | $44.72 | $2,191.28 |
DisclosureSEC source: 0001645279-16-000040 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,507 Underlying: Common Stock, $1 par value · 49 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| December 02, 2016 Filed Dec 6, 2016 21:11 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 50 | $44.01 | $2,200.50 |
DisclosureSEC source: 0001645279-16-000039 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,369 Underlying: Common Stock, $1 par value · 50 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 21:25 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 27 | $46.98 | $1,268.46 |
DisclosureSEC source: 0001645279-16-000038 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,361 Underlying: Common Stock, $1 par value · 27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 27 | $46.99 | $1,268.73 |
DisclosureSEC source: 0000899243-16-032928 · doc4.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,323 Underlying: Common Stock, $1 par value · 27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter International Inc.'s Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter International Inc.'s Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:06 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 27 | $48.18 | $1,300.86 |
DisclosureSEC source: 0001645279-16-000037 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,309 Underlying: Common Stock, $1 par value · 27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| October 07, 2016 Filed Oct 11, 2016 20:14 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxer Common Stock Fund · Derivative | 26 | $48.45 | $1,259.70 |
DisclosureSEC source: 0001645279-16-000036 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,257 Underlying: Common Stock, $1 par value · 26 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 20:09 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 27 | $47.49 | $1,282.23 |
DisclosureSEC source: 0001645279-16-000035 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,320 Underlying: Common Stock, $1 par value · 27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 20:07 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantDeferred Comp Plan Baxter Common Stock Fund · Derivative | 28 | $45.09 | $1,262.52 |
DisclosureSEC source: 0001645279-16-000034 · edgar.xml · derivative · entry 1 Felicelli Robert · CIK 0001645279 · CVP, Business Transformation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,330 Underlying: Common Stock, $1 par value · 28 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. F2 · derivative.expiration_date: Reporting person allocated compensation deferred under Baxter's Deferred Compensation Plan (the "Plan") to the Baxter Common Stock Fund notional investment alternative. Reporting person's account balance is payable subject to the terms of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.